0.9399
price down icon6.01%   -0.0601
after-market 시간 외 거래: .91 -0.0299 -3.18%
loading
전일 마감가:
$1.00
열려 있는:
$0.99
하루 거래량:
2.21M
Relative Volume:
1.18
시가총액:
$12.16M
수익:
-
순이익/손실:
$-9.70M
주가수익비율:
-0.8545
EPS:
-1.1
순현금흐름:
$-8.57M
1주 성능:
-18.97%
1개월 성능:
-39.75%
6개월 성능:
-38.37%
1년 성능:
-74.04%
1일 변동 폭
Value
$0.92
$1.00
1주일 범위
Value
$0.92
$1.40
52주 변동 폭
Value
$0.92
$5.95

마커 테라퓨틱스 Stock (MRKR) Company Profile

Name
명칭
Marker Therapeutics Inc
Name
전화
(713) 400-6400
Name
주소
2450 HOLCOMBE BLVD, HOUSTON, TX
Name
직원
5
Name
트위터
@MRKRTherapeutic
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
MRKR's Discussions on Twitter

MRKR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MRKR
Marker Therapeutics Inc
0.9399 12.94M 0 -9.70M -8.57M -1.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
389.08 99.27B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
586.96 62.28B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.18 59.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
707.96 43.34B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
300.14 36.72B 3.81B -644.79M -669.77M -6.24

마커 테라퓨틱스 Stock (MRKR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-05 개시 Canaccord Genuity Buy
2021-03-25 개시 Piper Sandler Overweight
2021-03-19 개시 Cantor Fitzgerald Overweight
2020-05-12 다운그레이드 Piper Sandler Overweight → Neutral
2019-05-30 개시 ROTH Capital Buy
2019-03-01 개시 Janney Buy
2018-12-03 업그레이드 Piper Jaffray Neutral → Overweight
모두보기

마커 테라퓨틱스 주식(MRKR)의 최신 뉴스

pulisher
05:09 AM

Analyzing Marker Therapeutics Inc. with risk reward ratio charts2025 Price Momentum & Fast Exit Strategy with Risk Control - Newser

05:09 AM
pulisher
12:09 PM

Marker Therapeutics (MRKR) Falls 20.6% After Positive Clinical Study - Insider Monkey

12:09 PM
pulisher
11:34 AM

Exit strategy if you’re trapped in Marker Therapeutics Inc.Weekly Stock Summary & Short-Term Trading Opportunity Alerts - Newser

11:34 AM
pulisher
11:27 AM

Is Marker Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser

11:27 AM
pulisher
10:31 AM

Is Marker Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - Newser

10:31 AM
pulisher
10:16 AM

Can trapped investors hope for a rebound in Marker Therapeutics Inc.July 2025 Highlights & AI Forecast Swing Trade Picks - Newser

10:16 AM
pulisher
05:59 AM

Marker Therapeutics Inc.’s volatility index tracking explained2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser

05:59 AM
pulisher
Aug 26, 2025

10 Stocks Losing Big - Insider Monkey

Aug 26, 2025
pulisher
Aug 26, 2025

Can you recover from losses in Marker Therapeutics Inc.Short Setup & Accurate Buy Signal Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Will Marker Therapeutics Inc. continue its uptrendOptions Play & Entry Point Confirmation Alerts - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Inc (MRKR) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Aug 26, 2025
pulisher
Aug 26, 2025

Published on: 2025-08-26 21:38:35 - beatles.ru

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Stock Drops After Report About Lymphoma Treatment - Benzinga

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics shares fall 14.29% intraday after a Phase I clinical update from the APOLLO study. - AInvest

Aug 26, 2025
pulisher
Aug 26, 2025

Transcript : Marker Therapeutics, Inc.Special Call - MarketScreener

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Faces Major Shift amidst Strategic Challenges - StocksToTrade

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics’ Shares Leaps: What’s Behind the Rise? - timothysykes.com

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics stock soars on promising Phase 1 lymphoma study data - Investing.com

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Says MT-401 Shows 66% Response Rate in Relapsed Lymphoma Study - MarketScreener

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Reports Promising Phase 1 Study Results - TipRanks

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics : Corporate Presentation - MarketScreener

Aug 26, 2025
pulisher
Aug 26, 2025

What earnings revisions data tells us about Marker Therapeutics Inc.2025 Short Interest & Free Growth Oriented Trading Recommendations - Newser

Aug 26, 2025
pulisher
Aug 26, 2025

Marker Therapeutics Provides Update on Phase 1 APOLLO Study - GlobeNewswire

Aug 26, 2025
pulisher
Aug 26, 2025

66% Response Rate: Marker's Novel T Cell Therapy Shows Promise for CAR-T Resistant Lymphoma Patients - Stock Titan

Aug 26, 2025
pulisher
Aug 26, 2025

Published on: 2025-08-26 05:28:09 - Newser

Aug 26, 2025
pulisher
Aug 25, 2025

Is it time to cut losses on Marker Therapeutics Inc.Earnings Performance Report & Weekly High Return Stock Forecasts - Newser

Aug 25, 2025
pulisher
Aug 24, 2025

Loss Report: What’s the outlook for Marker Therapeutics Inc.’s sectorJuly 2025 Outlook & Breakout Confirmation Trade Signals - theviewers.co.kr

Aug 24, 2025
pulisher
Aug 24, 2025

Will earnings trigger a reversal in Marker Therapeutics Inc.Weekly Trend Report & Low Drawdown Momentum Ideas - Newser

Aug 24, 2025
pulisher
Aug 23, 2025

Published on: 2025-08-23 15:45:36 - Newser

Aug 23, 2025
pulisher
Aug 23, 2025

Can machine learning forecast Marker Therapeutics Inc. recoveryMarket Activity Report & Technical Pattern Based Signals - Newser

Aug 23, 2025
pulisher
Aug 22, 2025

What are Marker Therapeutics Inc.’s growth leversJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - theviewers.co.kr

Aug 22, 2025
pulisher
Aug 22, 2025

Applying chart zones and confluence areas to Marker Therapeutics Inc.Portfolio Return Report & Real-Time Stock Movement Alerts - Newser

Aug 22, 2025
pulisher
Aug 22, 2025

Valuation Update: Will Marker Therapeutics Inc. benefit from rate cutsM&A Rumor & Daily Profit Maximizing Tips - theviewers.co.kr

Aug 22, 2025
pulisher
Aug 22, 2025

Chart Analysts Warn of Resistance Near Marker Therapeutics Inc. Price2025 Sector Review & Daily Stock Momentum Reports - beatles.ru

Aug 22, 2025
pulisher
Aug 22, 2025

Will Marker Therapeutics Inc. Hold Gains Into CloseMarket Risk Report & Weekly High Return Forecasts - classian.co.kr

Aug 22, 2025
pulisher
Aug 21, 2025

Fibonacci Support Holding Strong in Marker Therapeutics Inc.July 2025 Summary & Community Consensus Trade Signals - classian.co.kr

Aug 21, 2025
pulisher
Aug 21, 2025

Is Marker Therapeutics Inc. impacted by rising ratesOptions Play & Verified Momentum Stock Alerts - theviewers.co.kr

Aug 21, 2025
pulisher
Aug 20, 2025

Analysts Spot Bullish Divergence in Marker Therapeutics Inc.July 2025 WrapUp & Fast Exit and Entry Strategy Plans - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Marker Therapeutics Inc. Stock Approaches Key Moving Average2025 Volatility Report & Weekly Breakout Watchlists - 더경남뉴스

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-21 02:07:42 - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Using Ichimoku Cloud for Marker Therapeutics Inc. technicalsMarket Movement Recap & Daily Profit Focused Stock Screening - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Momentum divergence signals in Marker Therapeutics Inc. chartJuly 2025 News Drivers & High Conviction Buy Zone Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Watch for Bullish Crossover in Marker Therapeutics Inc.July 2025 Weekly Recap & Community Supported Trade Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Short interest data insights for Marker Therapeutics Inc.2025 Macro Impact & Low Risk Entry Point Tips - Newser

Aug 19, 2025

마커 테라퓨틱스 (MRKR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
자본화:     |  볼륨(24시간):